Mount Yale Investment Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Sell |
11,048
-108
| -1% | -$11.6K | 0.09% | 188 |
|
|
2025
Q1 | $1.13M | Sell |
11,156
-3,031
| -21% | -$306K | 0.1% | 179 |
|
|
2024
Q4 | $1.27M | Sell |
14,187
-2,607
| -16% | -$233K | 0.1% | 167 |
|
|
2024
Q3 | $1.41M | Buy |
16,794
+1,159
| +7% | +$97.1K | 0.14% | 156 |
|
|
2024
Q2 | $1.2M | Sell |
15,635
-1,234
| -7% | -$95K | 0.1% | 182 |
|
|
2024
Q1 | $1.16M | Buy |
16,869
+1,370
| +9% | +$93.8K | 0.09% | 196 |
|
|
2023
Q4 | $896K | Sell |
15,499
-55
| -0.4% | -$3.18K | 0.09% | 219 |
|
|
2023
Q3 | $821K | Buy |
15,554
+5,716
| +58% | +$302K | 0.09% | 218 |
|
|
2023
Q2 | $532K | Buy |
9,838
+73
| +0.7% | +$3.95K | 0.06% | 296 |
|
|
2023
Q1 | $489K | Buy |
+9,765
| New | +$489K | 0.05% | 302 |
|
|
2020
Q4 | – | Sell |
-18,113
| Closed | -$692K | – | 396 |
|
|
2020
Q3 | $692K | Buy |
18,113
+4,508
| +33% | +$172K | 0.1% | 197 |
|
|
2020
Q2 | $478K | Buy |
+13,605
| New | +$478K | 0.09% | 233 |
|
|
2018
Q4 | – | Sell |
-4,043
| Closed | -$153K | – | 373 |
|
|
2018
Q3 | $153K | Buy |
4,043
+1,980
| +96% | +$74.9K | 0.03% | 328 |
|
|
2018
Q2 | $67K | Buy |
2,063
+314
| +18% | +$10.2K | 0.01% | 571 |
|
|
2018
Q1 | $48K | Buy |
+1,749
| New | +$48K | 0.01% | 620 |
|